Patent classifications
A61B10/0051
HEALTH TESTING AND DIAGNOSTICS PLATFORM
Systems and methods for providing a universal platform for at-home health testing and diagnostics are provided herein. In particular, a health testing and diagnostic platform is provided to connect medical providers with patients and to generate a unique, private testing environment. In some embodiments, the testing environment may facilitate administration of a medical test to a patient with the guidance of a proctor. In some embodiments, the patient may be provided with step-by-step instructions for test administration by the proctor within a testing environment. The platform may display unique, dynamic testing interfaces to the patient and proctor to ensure proper testing protocols and accurate test result verification.
Physical methods for living tissue inactivation and detection, and physical methods in use for the detection and inactivation of living bodies (like Ebola and 2019 Coronavirus) in living systems and non-living systems thereof
A system for detecting presence of coronavirus in a subject, the system including a first pad for placing a first hand, the pad including a contact to measure conductance of the subject's body, a conductance meter connected to the contact, a second pad for placing a second hand, a source of electromagnetic radiation for irradiating the second pad. A system for detecting presence of coronavirus in a subject, the system including a chip with a plurality of wires disposed on or in the chip, a conductance meter arranged to measure conductance between the wires, and biological material associated with the coronavirus disposed on or in the chip. Related apparatus and methods are also described.
SAMPLING DEVICE
The device comprises a nib (12) having a working surface (16) exposed or exposable for acquiring a biological sample and a porous structure to absorb the sample thus acquired. A reservoir (28) provides fluid under pressure to the nib via a valve (29), conveying and dispensing the sample into a reaction chamber (14), where it reconstitutes a dried-down reagent (43) to perform an analytic reaction on the sample, for example, an isothermal amplification of nucleic acid released from the sample by a membrane-disrupting agent pre-functionalised in the porous nib. The nib may be initially mounted (A) in the outlet of the reservoir or (B) in the inlet to the reaction chamber, in either case with its working surface (16) initially exposed to acquire the sample before the components of the device are assembled for performing the analytical procedure.
Vertical flow assay device for detecting glucose concentration in a fluid sample
A glycemic management related analyte detecting assay device (10) and method are provided for detecting and quantifying analyte concentrations in a fluid sample. The assay device includes an absorbent body containing an assay forming a detection zone for receiving a fluid test sample. The absorbent body is provided in a chamber of the device. The assay can detect one or more of a glycemic analyte selected from the group consisting of fasting plasma blood glucose, oral glucose, % glycated hemoglobin, and fasting insulin concentrations. In one embodiment, a container includes an absorbent body having a plurality of superimposed membranes (30, 32, 34, 36) where each membrane contains a reactant and a color indicator for detecting the presence of a selected analyte above a predetermined concentration in the fluid sample. The absorbent body and/or the assay include a color indicator that is able to provide a visual indication of the presence of one or more glycemic analytes present in the test sample.
METHODS FOR APPLICATION SPECIFIC ACCESS CONTROL
A method implemented on a UE includes determining an application class of an application, and permitting or barring access by the application to a communication network according to a comparison of the determined application with a rule to provide application class based access control. The application is classified into the determined application class. The application is classified into the determined application class by a home network. The application is classified into the determined application class by a 3GPP layer. The application is classified into the determined application class by a visited network. The visited network classifies the application into a further application class. The rule includes a list of applications for permitting or barring access by the applications according to the comparison of the determined application class with the rule.
Saliva test strip and method
A test strip for sampling a bodily fluid may include multiple layers of a substrate material, an adhesive between at least some of the multiple layers, and a microfluidic channel formed between at least some of the multiple layers. The test strip may further include multiple electrodes on one of the multiple layers, positioned and partially exposed within the microfluidic channel, an additional material positioned at or near an entrance to the microfluidic channel, to selectively limit the flow of at least one of bubbles or debris into the microfluidic channel, and at least one exit port in at least one of the multiple layers to allow for release of pressure from the test strip. In some embodiments, the test strip is a saliva analysis test strip. In some embodiments, the test strip includes multiple exit ports to prevent blockage of sample flow.
DETECTING CYANIDE EXPOSURE BASED ON THIOCYANATE MEASUREMENT IN SALIVA
In an example, a method of detecting cyanide exposure of an individual includes: measuring a thiocyanate level of the individual which includes placing saliva of the individual in contact with a chemical indicator to measure the thiocyanate level and measuring thiocyanate (SCN.sup.−) catalyzed by enzyme rhodanese of the individual; comparing the measured thiocyanate level to a preset thiocyanate threshold to determine whether the measured thiocyanate level is above the preset thiocyanate threshold indicating a level of cyanide poisoning for which a medical procedure is recommended to manage health effects of the exposure; and performing the medical procedure if the measured thiocyanate level is above the preset thiocyanate threshold and not performing the medical procedure if the measured thiocyanate level is not above the preset thiocyanate threshold.
LIQUID COLLECTOR
An embodiment of the present disclosure provides a liquid collector that collects liquid, the liquid collector including: a flow passage member including a flow passage that connects one end and other end of the flow passage member; a contact member that is disposed at the one end of the flow passage member, that includes an elastic material, and that is configured to come into contact with a target from which liquid is to be collected; and a container that receives the liquid discharged from the flow passage at the other end of the flow passage member.
DEVICE FOR COLLECTING TEST SPECIMEN
The present invention provides a device for collecting a fluid specimen. The device comprises a water-absorbing end part formed by bonding a first porous water-absorbing film and a second porous water-absorbing film. Preferably, the second porous water-absorbing film and the first porous water-absorbing film are sponge films.
TESTING SYSTEM
A testing system collects a specimen from a subject and measures the collected specimen to test the specimen, and includes a box to allow at least one of specimen collection for collecting and receiving the specimen, preprocessing for processing the collected specimen before measurement, or specimen measurement for measuring the preprocessed specimen to be performed therein.